National and international developments in cancer, health and policy. Produced in collaboration with the Press Association unless otherwise stated.
100% of the profits from all sales on our online shop go towards our life-saving research.
At least 14,000 fewer people have been urgently referred for lung cancer tests since March.
The National Institute for Health and Care Excellence has approved the drug osimertinib to treat some adults in England with untreated, advanced lung cancer.
Cancer drug lenalidomide receives an initial rejection to treat some adults with myeloma following a stem cell transplant.
A drug combination for people with a rare type of bowel cancer has received an initial rejection from the National Institute for Health and Care Excellence.